272 related articles for article (PubMed ID: 35470077)
1. Iron ion and sulfasalazine-loaded polydopamine nanoparticles for Fenton reaction and glutathione peroxidase 4 inactivation for enhanced cancer ferrotherapy.
Zhu X; Chen Q; Xie L; Chen W; Jiang Y; Song E; Song Y
Acta Biomater; 2022 Jun; 145():210-221. PubMed ID: 35470077
[TBL] [Abstract][Full Text] [Related]
2. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
[TBL] [Abstract][Full Text] [Related]
3. Synergistic hydroxyl radical formation, system XC- inhibition and heat shock protein crosslinking tango in ferrotherapy: A prove-of-concept study of "sword and shield" theory.
Xie L; Chen W; Chen Q; Jiang Y; Song E; Zhu X; Song Y
Mater Today Bio; 2022 Dec; 16():100353. PubMed ID: 35865409
[TBL] [Abstract][Full Text] [Related]
4. A multi-mode Rhein-based nano-platform synergizing ferrotherapy/chemotherapy-induced immunotherapy for enhanced tumor therapy.
Zhu X; Xie L; Tian J; Jiang Y; Song E; Song Y
Acta Biomater; 2024 May; 180():383-393. PubMed ID: 38570106
[TBL] [Abstract][Full Text] [Related]
5. Tumor Microenvironment-Responsive Nanodrug for Clear-Cell Renal Cell Carcinoma Therapy via Triggering Waterfall-Like Cascade Ferroptosis.
Ni W; Li Y; Liang L; Yang S; Zhan M; Lu C; Lu L; Wen L
J Biomed Nanotechnol; 2022 Feb; 18(2):327-342. PubMed ID: 35484753
[TBL] [Abstract][Full Text] [Related]
6. A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis.
Luo S; Ma D; Wei R; Yao W; Pang X; Wang Y; Xu X; Wei X; Guo Y; Jiang X; Yuan Y; Yang R
Acta Biomater; 2022 Jan; 138():518-527. PubMed ID: 34775124
[TBL] [Abstract][Full Text] [Related]
7. pH-Responsive Sorafenib/Iron-Co-Loaded Mesoporous Polydopamine Nanoparticles for Synergistic Ferroptosis and Photothermal Therapy.
Liu S; Liu Y; Chang Q; Celia C; Deng X; Xie Y
Biomacromolecules; 2024 Jan; 25(1):522-531. PubMed ID: 38087829
[TBL] [Abstract][Full Text] [Related]
8. NIR Light-Activated and RGD-Conjugated Ultrasmall Fe/PPy Nanopolymers for Enhanced Tumor Photothermal Ferrotherapy and MR Imaging.
Zhang X; Wang T; Zhou Z; Zhao T; Shen Y; Fang W
Chemistry; 2023 Nov; 29(66):e202302125. PubMed ID: 37673787
[TBL] [Abstract][Full Text] [Related]
9. Enhanced photothermal-ferroptosis effects based on RBCm-coated PDA nanoparticles for effective cancer therapy.
Yu H; Yan J; Li Z; Song T; Ning F; Tan J; Sun Y
J Mater Chem B; 2023 Jan; 11(2):415-429. PubMed ID: 36512437
[TBL] [Abstract][Full Text] [Related]
10. Manganese-containing polydopamine nanoparticles as theranostic agents for magnetic resonance imaging and photothermal/chemodynamic combined ferroptosis therapy treating gastric cancer.
Chen Z; Li Z; Li C; Huang H; Ren Y; Li Z; Hu Y; Guo W
Drug Deliv; 2022 Dec; 29(1):1201-1211. PubMed ID: 35403518
[TBL] [Abstract][Full Text] [Related]
11. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X
Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851
[TBL] [Abstract][Full Text] [Related]
12. An all-in-one biomimetic iron-small interfering RNA nanoplatform induces ferroptosis for cancer therapy.
Huang S; Le H; Hong G; Chen G; Zhang F; Lu L; Zhang X; Qiu Y; Wang Z; Zhang Q; Ouyang G; Shen J
Acta Biomater; 2022 Aug; 148():244-257. PubMed ID: 35709941
[TBL] [Abstract][Full Text] [Related]
13. Delivery of a system x
Xin H; Huang Y; Tang H; Chen Y; Xia H; Zhang F; Li B; Ping Y
J Mater Chem B; 2021 Sep; 9(35):7172-7181. PubMed ID: 34369535
[TBL] [Abstract][Full Text] [Related]
14. Iron-based metal-organic framework co-loaded with buthionine sulfoximine and oxaliplatin for enhanced cancer chemo-ferrotherapy via sustainable glutathione elimination.
Rao Z; Xia Y; Jia Q; Zhu Y; Wang L; Liu G; Liu X; Yang P; Ning P; Zhang R; Zhang X; Qiao C; Wang Z
J Nanobiotechnology; 2023 Aug; 21(1):265. PubMed ID: 37563614
[TBL] [Abstract][Full Text] [Related]
15. A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy.
Hu X; Li R; Wu W; Fang K; Zhu Z; Wang Y; Zhou L; Chen M; Dong C; Shi S
J Control Release; 2022 Aug; 348():660-671. PubMed ID: 35716884
[TBL] [Abstract][Full Text] [Related]
16. An active-passive strategy for enhanced synergistic photothermal-ferroptosis therapy in the NIR-I/II biowindows.
Wu F; Chen H; Liu R; Suo Y; Li Q; Zhang Y; Liu H; Cheng Z; Chang Y
Biomater Sci; 2022 Feb; 10(4):1104-1112. PubMed ID: 35044388
[TBL] [Abstract][Full Text] [Related]
17. Complementing Cancer Photodynamic Therapy with Ferroptosis through Iron Oxide Loaded Porphyrin-Grafted Lipid Nanoparticles.
Liang X; Chen M; Bhattarai P; Hameed S; Tang Y; Dai Z
ACS Nano; 2021 Dec; 15(12):20164-20180. PubMed ID: 34898184
[TBL] [Abstract][Full Text] [Related]
18. Iron plays a role in sulfasalazine-induced ferroptosis with autophagic flux blockage in K7M2 osteosarcoma cells.
Liu J; Lou C; Zhen C; Wang Y; Shang P; Lv H
Metallomics; 2022 May; 14(5):. PubMed ID: 35441682
[TBL] [Abstract][Full Text] [Related]
19. An iron oxyhydroxide-based nanosystem sensitizes ferroptosis by a "Three-Pronged" strategy in breast cancer stem cells.
Wu K; Zhang W; Chen H; Wu J; Wang X; Yang X; Liang XJ; Zhang J; Liu D
Acta Biomater; 2023 Apr; 160():281-296. PubMed ID: 36822484
[TBL] [Abstract][Full Text] [Related]
20. Iron-based nanoparticles for MR imaging-guided ferroptosis in combination with photodynamic therapy to enhance cancer treatment.
Chen Q; Ma X; Xie L; Chen W; Xu Z; Song E; Zhu X; Song Y
Nanoscale; 2021 Mar; 13(9):4855-4870. PubMed ID: 33624647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
